-
1
المؤلفون: Moa Lugner, Jan Ekelund, Stefan Franzén, Ann-Marie Svensson, Mervete Miftaraj, Naveed Sattar, Björn Eliasson
المصدر: Cardiovascular Diabetology, Vol 20, Iss 1, Pp 1-11 (2021)
Cardiovascular Diabetologyمصطلحات موضوعية: Blood Glucose, Male, medicine.medical_specialty, lcsh:Diseases of the circulatory (Cardiovascular) system, Time Factors, Databases, Factual, Epidemiology, Endocrinology, Diabetes and Metabolism, Sodium glucose transporter 2 inhibitors, Type 2 diabetes, Lower risk, Incretins, Risk Assessment, Glucagon-Like Peptide-1 Receptor, Risk Factors, Internal medicine, Diabetes mellitus, medicine, Humans, Registries, Mortality, Stroke, Sodium-Glucose Transporter 2 Inhibitors, Aged, Original Investigation, Glycated Hemoglobin, Sweden, Proportional hazards model, business.industry, Middle Aged, medicine.disease, Cardiovascular disease, Glucagon‐like peptide-1 receptor agonist, Treatment Outcome, Diabetes Mellitus, Type 2, Cardiovascular Diseases, lcsh:RC666-701, Heart failure, Observational study, Female, Kidney Diseases, Cardiology and Cardiovascular Medicine, business, Mace, Biomarkers
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4930f288101c166347ff8803e473c98fTest
https://doaj.org/article/6fc3ecc984ff4d4bb98abed4139eb706Test -
2
المؤلفون: Fahri Bayram, Katerina Urbancova, Capture Study Investigators, Abdullah M. Alguwaihes, Shinichiro Shirabe, Csaba Lengyel, Guillermo Dieuzeide, Ofri Mosenzon, Jose Luis A. Leon, Nicolai Rhee, Giuseppina T. Russo, Sergio Vencio, Margit S Kaltoft, Patrice Darmon, Timothy M. E. Davis, Kirsten T. Eriksen, Tianpei Hong
المساهمون: The Hebrew University of Jerusalem (HUJ), King Saud University [Riyadh] (KSU), Erciyes University, Centre recherche en CardioVasculaire et Nutrition = Center for CardioVascular and Nutrition research (C2VN), Aix Marseille Université (AMU)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Institut National de Recherche pour l’Agriculture, l’Alimentation et l’Environnement (INRAE), The University of Western Australia (UWA), Novo Nordisk Inc, NOVO NORDISK PARK, Peking University [Beijing], University of Szeged [Szeged], Novo nordisk pharma, University of Messina
المصدر: Cardiovascular Diabetology, Vol 20, Iss 1, Pp 1-13 (2021)
Cardiovascular Diabetology
Cardiovascular Diabetology, 2021, 20 (1), pp.154. ⟨10.1186/s12933-021-01344-0⟩مصطلحات موضوعية: Male, medicine.medical_specialty, Time Factors, Cross-sectional study, [SDV]Life Sciences [q-bio], Endocrinology, Diabetes and Metabolism, Prevalence, Type 2 diabetes, Non-interventional study, Risk Assessment, Glucagon-like peptide-1 receptor agonists, chemistry.chemical_compound, Interquartile range, Risk Factors, Diabetes mellitus, Internal medicine, medicine, Humans, Hypoglycemic Agents, Diseases of the circulatory (Cardiovascular) system, Original Investigation, Aged, business.industry, Odds ratio, Middle Aged, Protective Factors, medicine.disease, Prognosis, Cardiovascular disease, Confidence interval, Cross-Sectional Studies, chemistry, Diabetes Mellitus, Type 2, Cardiovascular Diseases, Atherosclerotic cardiovascular disease, RC666-701, Female, Glycated hemoglobin, Cardiology and Cardiovascular Medicine, business, Sodium-glucose co-transporter-2 inhibitors, Demography
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6c0c647e392a328eb4db221b67cb91bcTest
https://doaj.org/article/67a5ab1adb4e4cf9b4f165303e5e0c48Test -
3
المؤلفون: Majed S. Al Yami, Omar S. Alkhezi, Abdulaali R. Almutairi, Omar A. Almohammed, Osamah M. Alfayez
المصدر: Cardiovascular Diabetology, Vol 19, Iss 1, Pp 1-14 (2020)
Cardiovascular Diabetologyمصطلحات موضوعية: Blood Glucose, Male, medicine.medical_specialty, lcsh:Diseases of the circulatory (Cardiovascular) system, Time Factors, Endocrinology, Diabetes and Metabolism, Network Meta-Analysis, Heart failure, Incretins, Risk Assessment, Glucagon-Like Peptide-1 Receptor, Lixisenatide, chemistry.chemical_compound, Diabetes mellitus, Risk Factors, Internal medicine, Medicine, Humans, Hypoglycemic Agents, Stroke, Aged, Original Investigation, Clinical Trials as Topic, business.industry, Semaglutide, Middle Aged, Protective Factors, medicine.disease, Cardiovascular disease, Albiglutide, Meta-analysis, Myocardial infarction, Treatment Outcome, chemistry, Diabetes Mellitus, Type 2, Cardiovascular Diseases, lcsh:RC666-701, Dulaglutide, Female, Cardiology and Cardiovascular Medicine, business, Exenatide, Biomarkers, Type 2, medicine.drug
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::716cea27f9cd1987bcca03bc52e2a8e7Test
http://link.springer.com/article/10.1186/s12933-020-01070-zTest